The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
Clinical trial NCT06254521 · RECRUITING
Trial details
- NCT number
- NCT06254521
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2024-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.